The landscape of blood sugar treatment is changing with the emergence of transdermal GLP-1 delivery . These convenient delivery systems offer a potentially less invasive alternative to needle administrations for individuals managing diabetes mellitus type 2 . These patches deliver a GLP-1 agonist